INCOME STATEMENT
J B Chemicals & Pharmaceuticals Ltd.
BSE
Jul 04
1637.05
-2.20 ( -0.13%)
Volume
814295
Prev. Close
1639.25
Open Price
1630.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jul 04
1638.10
-1.30 ( -0.08%)
Volume
1117679
Prev. Close
1639.40
Open Price
1632.10
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
ISIN No
|
INE572A01036
|
Market Cap. ( ₹ in Cr. )
|
25564.01
|
P/BV
|
7.96
|
Book Value ( ₹ )
|
205.84
|
BSE Code
|
506943
|
52 Week High/Low ( ₹ )
|
2030/1386
|
FV/ML
|
1/1
|
P/E(X)
|
38.76
|
NSE Code
|
JBCHEPHARMEQ
|
Book Closure
|
08/02/2025
|
EPS ( ₹ )
|
42.26
|
Div Yield (%)
|
0.95
|
(₹ in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 3722.92 | 3263.21 | 2855.42 | 2162.39 | 1849.08 |
Other Operating Revenues | 0.00 | 35.43 | 28.74 | 27.48 | 42.92 |
Total Operating Revenues | 3722.92 | 3298.64 | 2884.16 | 2189.88 | 1892.00 |
| | | | | |
Other Income | 34.74 | 34.67 | 8.65 | 38.61 | 111.89 |
Total Revenue | 3757.66 | 3333.32 | 2892.81 | 2228.49 | 2003.88 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 820.04 | 816.05 | 783.78 | 601.87 | 542.17 |
Purchase Of Stock-In Trade | 416.65 | 342.25 | 280.43 | 167.40 | 99.29 |
Changes In Inventories Of FG,WIP And Stock-In Trade | 15.53 | -49.22 | -27.48 | -25.57 | -15.70 |
Employee Benefit Expenses | 646.79 | 565.38 | 499.95 | 399.06 | 305.98 |
Finance Costs | 9.12 | 40.52 | 34.31 | 4.95 | 7.19 |
Depreciation And Amortisation Expenses | 166.45 | 135.24 | 111.99 | 71.28 | 67.36 |
Other Expenses | 805.97 | 744.77 | 682.80 | 538.21 | 403.89 |
Total Expenses | 2880.55 | 2594.98 | 2365.77 | 1757.20 | 1410.18 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 877.11 | 738.34 | 527.04 | 471.29 | 593.71 |
| | | | | |
Profit/Loss Before Tax | 877.11 | 738.34 | 527.04 | 471.29 | 593.71 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 224.57 | 145.10 | 83.35 | 122.50 | 137.50 |
Deferred Tax | 0.00 | 49.49 | 54.80 | -12.21 | 9.12 |
Tax For Earlier Years | 0.00 | 0.39 | 0.00 | 0.00 | 0.00 |
Total Tax Expenses | 224.57 | 194.98 | 138.15 | 110.29 | 146.62 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 652.54 | 543.36 | 388.89 | 361.00 | 447.08 |
| | | | | |
Profit/Loss From Continuing Operations | 652.54 | 543.36 | 388.89 | 361.00 | 447.08 |
| | | | | |
Profit/Loss For The Period | 652.54 | 543.36 | 388.89 | 361.00 | 447.08 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 42.00 | 35.07 | 50.29 | 46.71 | 57.85 |
Diluted EPS (Rs.) | 41.16 | 34.30 | 49.69 | 46.71 | 57.85 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 0.00 | 156.99 | 127.59 | 127.52 | 73.42 |
Equity Dividend Rate (%) | 1550.00 | 1225.00 | 887.50 | 825.00 | 825.00 |